Results 91 to 100 of about 18,344 (221)

Formoterol Acting via β2-Adrenoreceptor Restores Mitochondrial Dysfunction Caused by Parkinson’s Disease-Related UQCRC1 Mutation and Improves Mitochondrial Homeostasis Including Dynamic and Transport

open access: yesBiology
Formoterol, a β2-adrenergic receptor (β2AR) agonist, shows promise in various diseases, but its effectiveness in Parkinson’s disease (PD) is debated, with unclear regulation of mitochondrial homeostasis.
Jui-Chih Chang   +8 more
doaj   +1 more source

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study

open access: yesJournal of Asthma and Allergy, 2022
Yoshihisa Ishiura,1 Masaki Fujimura,2 Noriyuki Ohkura,3 Johsuke Hara,3 Kahori Nakahama,1 Yusuke Sawai,1 Takeshi Tamaki,1 Ryuta Murai,1 Toshiki Shimizu,1 Naoyuki Miyashita,1 Shosaku Nomura1 1First Department of Internal Medicine, Kansai Medical University,
Ishiura Y   +10 more
doaj  

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial

open access: yesBMC Pulmonary Medicine, 2012
Background This study investigated the efficacy and safety of a new asthma therapy combining fluticasone propionate and formoterol fumarate (fluticasone/formoterol; flutiform®), administered twice daily (b.i.d.) via a single aerosol inhaler, compared ...
Nathan Robert A   +3 more
doaj   +1 more source

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. [PDF]

open access: yes, 2014
BACKGROUND: Pharmacological therapy for chronic obstructive pulmonary disease (COPD) is aimed at relieving symptoms, improving quality of life and preventing or treating exacerbations.Treatment tends to begin with one inhaler, and additional therapies ...
Aalbers   +511 more
core   +1 more source

Get SMART? Understanding Pediatric Pulmonologists' Perspectives on Implementation of SMART

open access: yes
Pediatric Pulmonology, Volume 61, Issue 3, March 2026.
Charles Slocum   +4 more
wiley   +1 more source

Education in Family Medicine : What has been achieved? [PDF]

open access: yes, 2012
Contents: Education... historical landmarks - Pierre Mallia; The Malta College of Family Doctors and the Royal College of General Practitioners - John V.
Agius, Dominic   +2 more
core  

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease [PDF]

open access: yes, 2012
BackgroundLong-acting bronchodilators comprising long-acting beta(2)-agonists and the anticholinergic agent tiotropium are commonly used for managing persistent symptoms of chronic obstructive pulmonary disease.
Aaron   +47 more
core   +1 more source

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

open access: yesInternational Journal of COPD, 2017
Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol.
Ganapathy V, Stensland MD
doaj  

Cost-effectiveness of budesonide-formoterol in maintenance therapy of asthma patients at Mexico’s National Center for Respiratory Diseases.

open access: yesRevista Alergia México
Objective: to perform a cost-effectiveness analysis of asthma treatment with budesonide/formoterol against other treatment options used at Mexico’s National Institute for Respiratory Diseases.
María del Carmen Cano-Salas   +10 more
doaj   +1 more source

Resposta broncodilatadora imediata ao formoterol em doença pulmonar obstrutiva crônica com pouca reversibilidade Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease

open access: yesJornal Brasileiro de Pneumologia, 2008
OBJETIVO: Avaliar, por meio de provas de função pulmonar, a eficácia broncodilatadora do formoterol após 30 min de sua administração em portadores de doença pulmonar obstrutiva crônica (DPOC) com pouca reversibilidade.
Adalberto Sperb Rubin   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy